Search

Search Constraints

You searched for: Author/Creator Ogitani, Yusuke

Search Results

2. DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance. Issue 8 (12th July 2017)

3. Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads. Issue 6 (15th March 2016)

5. Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study. Issue 11 (November 2017)

6. Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology. Issue 20 (15th October 2016)